Jason Stubbs, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease (NCT02738905) | Jason Stubbs, MD | 2016-01-01 |
| Rifaximin Therapy in Chronic Kidney Disease (NCT02342639) | Jason Stubbs, MD | 2015-06-01 |
Track Jason Stubbs, MD automatically
Every clearance here is in the API, with alerts when new ones post.